Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
This recall is associated with reported fatalities. Consumers should take immediate action.
Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
MiramarLab, of Doral, Florida · Mamisan Pain Relieving Topical Ointment



Product Description
This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.
Hazard
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
Remedy
Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.
411 Press Analysis
MiramarLab, of Doral, Florida is recalling about 50,330 of Mamisan Pain Relieving Topical Ointment following reports of fatalities linked to the product. The CPSC announced this recall on December 18, 2025. The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. This is among the most serious recall classifications issued by the CPSC. Consumers are urged to stop use immediately and schedule a free repair. Anyone who has experienced problems with this product should file a report with the CPSC at SaferProducts.gov in addition to contacting the manufacturer.